Discounted Cash Flow
Pediatrix Medical Group, Inc.
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2016 | $3.2b | $324.9m | $382.8m | 10.2% | $3.52 |
| 2017 | $3.5b (8.6%) | $320.4m (-1.4%) | $483.7m (26.3%) | 9.3% (-9.2%) | $3.47 (-1.4%) |
| 2018 | $3.6b (5.5%) | $268.6m (-16.2%) | $274.0m (-43.3%) | 7.4% (-20.5%) | $2.95 (-15.0%) |
| 2019 | $3.5b (-3.7%) | $-1.5b (-657.5%) | $311.5m (13.7%) | -42.6% (-678.7%) | $-17.94 (-708.1%) |
| 2020 | $1.7b (-50.6%) | $-796.5m (46.8%) | $142.8m (-54.2%) | -45.9% (-7.8%) | $-9.55 (46.8%) |
| 2021 | $1.9b (10.2%) | $131.0m (116.4%) | $61.7m (-56.8%) | 6.9% (114.9%) | $1.54 (116.1%) |
| 2022 | $2.0b (3.2%) | $66.3m (-49.3%) | $165.0m (167.4%) | 3.4% (-50.9%) | $0.79 (-48.7%) |
| 2023 | $2.0b (1.1%) | $-60.4m (-191.1%) | $114.2m (-30.8%) | -3.0% (-190.0%) | $0.73 (-7.6%) |
| 2024 | $2.0b (0.9%) | $-99.1m (-64.0%) | $152.7m (33.7%) | -4.9% (-62.5%) | $-1.19 (-263.0%) |
| 2025 | $1.9b (-4.9%) | $165.4m (266.9%) | $244.9m (60.4%) | 8.6% (275.6%) | $1.97 (265.5%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Values abbreviated: b = billions, m = millions, k = thousands.
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.